Physician profile
Amanda Ryan
NPI 1689756595
$10,235.59
in general payments reported to CMS, 2019-2025
26 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $361 · 2021: $811 · 2022: $763 · 2023: $2,602 · 2024: $4,623 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,820 · Travel and Lodging: $2,438 · Food and Beverage: $2,266 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,820.00 |
| Travel and Lodging | $2,438.46 |
| Food and Beverage | $2,265.65 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $4,900.38 | 2019-2025 | (9520) Igt Devices Undivided, (6578) Visions 018, (Bh4) Igt Devices Undivided |
| Medtronic, INC. | $1,355.83 | 2023-2025 | Abre, Azure Xt Dr Mri Surescan, Venaseal |
| Terumo Medical Corporation | $664.01 | 2019-2023 | Glidesheath Slender |
| Boston Scientific Corporation | $652.45 | 2019-2023 | Synergy, Avvigo Guidance System |
| Abbott Laboratories | $335.88 | 2020-2025 | Assurity |
| Astrazeneca Pharmaceuticals LP | $271.54 | 2019-2023 | Farxiga |
| Abiomed | $247.66 | 2019-2024 | Impella |
| Janssen Pharmaceuticals, INC | $246.86 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.52 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $219.43 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $209.64 | 2023-2025 | Camzyos, Eliquis |
| Cordis US Corp. | $140.42 | 2022-2024 | Mynx Venous Vcd, Adroit |
| Amgen INC. | $126.02 | 2023-2024 | Repatha |
| Pfizer INC. | $112.49 | 2020-2021 | |
| Tactile Systems Technology INC | $111.45 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $97.58 | 2020-2023 | |
| Irhythm Technologies, INC. | $71.53 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Davol INC. | $51.66 | 2021 | |
| Bard Peripheral Vascular, INC. | $35.76 | 2025 | Venovo |
| Amarin Pharma, INC. | $32.57 | 2021 | |
| Inari Medical, INC. | $25.30 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $23.12 | 2025 | Wegovy |
| Edwards Lifesciences Corporation | $19.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.19 | 2021 | |
| Scpharmaceuticals INC. | $15.45 | 2025 | |
| Medtronic Vascular, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.